Crescita Therapeutics (TSX:CTX) Other Operating Expense : C$1.76 Mil (TTM As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Crescita Therapeutics Other Operating Expense?

Crescita Therapeutics's Other Operating Expense for the three months ended in Mar. 2024 was C$0.63 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was C$1.76 Mil.

Crescita Therapeutics's quarterly Other Operating Expense increased from Sep. 2023 (C$0.38 Mil) to Dec. 2023 (C$0.38 Mil) and increased from Dec. 2023 (C$0.38 Mil) to Mar. 2024 (C$0.63 Mil).

Crescita Therapeutics's annual Other Operating Expense increased from Dec. 2021 (C$1.38 Mil) to Dec. 2022 (C$1.47 Mil) and increased from Dec. 2022 (C$1.47 Mil) to Dec. 2023 (C$1.51 Mil).

Crescita Therapeutics Other Operating Expense Historical Data

The historical data trend for Crescita Therapeutics's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Crescita Therapeutics Other Operating Expense Chart

Crescita Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

1.73

1.49

1.38

1.47

1.51

Crescita Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Operating Expense	Get a 7-Day Free Trial															0.61	0.38	0.38	0.38	0.63

Crescita Therapeutics Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$1.76 Mil.

Crescita Therapeutics Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Crescita Therapeutics's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Crescita Therapeutics (TSX:CTX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Crescita Therapeutics Inc (TSX:CTX) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

CRRTF:USA

Address

2805, Place Louis-R-Renaud, Laval, QC, CAN, H7V 0A3

Website

https://www.crescitatherapeutics.com

Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The company has three reportable segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The firm generates its revenue in the form of product sales and out-licensing revenue.

Executives

Knight Therapeutics Inc.

10% Security Holder

Crescita Therapeutics (TSX:CTX) Headlines

No Headlines